Status:
COMPLETED
Virtual Reality to Alleviate Claustrophobia During MRI
Lead Sponsor:
Ecole Polytechnique Fédérale de Lausanne
Collaborating Sponsors:
University Hospital, Geneva
Conditions:
Claustrophobia
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This study evaluates if our Virtual Reality (VR) simulation inside the MRI efficiently alleviates symptoms of claustrophobia for patients during the MRI examination.
Detailed Description
Anxiety of claustrophobic patients during MRI scan leads to movements of patients (which cause imaging artefacts), interruptions or even abortions of imaging scans, eventually requiring to reschedule ...
Eligibility Criteria
Inclusion
- indicating suffering from claustrophobia
- Be aged between 18 and 40 year-old
- Being able to give consent
- Being able to understand and speak French or English
- Being MRI-compatible
Exclusion
- Epilepsy or illnesses affecting the brain, such as HIV, Lyme disease or meningitis
- Psychiatric disorders, such as schizophrenia, autism, obsessive compulsive disorder.
- History of 1 year or more of addiction to drugs such as cannabis, alcohol, cocain, heroine, LSD.
- Taking sleeping pills or anti-anxiety medication before the exam
Key Trial Info
Start Date :
July 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04754958
Start Date
July 20 2021
End Date
February 28 2024
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopitaux Universitaires de Geneve (HUG)
Geneva, Switzerland, 1205